Monogram Biosciences to Present at the Collins Stewart Fourth Annual Growth Conference
July 01 2008 - 7:00AM
PR Newswire (US)
SOUTH SAN FRANCISCO, Calif., July 1 /PRNewswire-FirstCall/ --
Monogram Biosciences, Inc. (NASDAQ:MGRM) announced today that
William D. Young, CEO and Chairman, is scheduled to present an
update on the company's business at the Collins Stewart LLC Fourth
Annual Growth Conference on Tuesday, July 8, 2008 at 9:00 a.m.
(Eastern Time) at the Mandarin Oriental Hotel in New York, NY. To
access the live audio broadcast or the subsequent archived
recording, log on to http://www.monogrambio.com/ and go to the
investor relations section ("Investors/Media" tab) and click on the
"Events & Webcasts" link provided on the sidebar menu on the
page. About Monogram Biosciences, Inc. Monogram is advancing
individualized medicine by discovering, developing and marketing
innovative products to guide and improve treatment of serious
infectious diseases and cancer. The Company's products are designed
to help doctors optimize treatment regimens for their patients that
lead to better outcomes and reduced costs. The Company's technology
is also being used by numerous biopharmaceutical companies to
develop new and improved antiviral therapeutics and vaccines as
well as targeted cancer therapeutics. More information about the
Company and its technology can be found on its web site at
http://www.monogrambio.com/ contacts: Alfred G. Merriweather
Jeremiah Hall Chief Financial Officer Feinstein Kean Healthcare
Tel: 650 624-4576 Tel: 415 677-2700 DATASOURCE: Monogram
Biosciences, Inc. CONTACT: Alfred G. Merriweather, Chief Financial
Officer of Monogram Biosciences, Inc., +1-650-624-4576, ; Jeremiah
Hall of Feinstein Kean Healthcare, +1-415-677-2700, Web site:
http://www.monogrambio.com/
Copyright
Monogram Technologies (NASDAQ:MGRM)
Historical Stock Chart
From Jun 2024 to Jul 2024
Monogram Technologies (NASDAQ:MGRM)
Historical Stock Chart
From Jul 2023 to Jul 2024